Enhanced morphine-induced antinociception in histamine H3 receptor gene knockout mice

Neuropharmacology

Volumn 57, Issue 4, 2009, Pages 409-414

  Mobarakeh, Jalal Izadi ^a,b   Takahashi, Kazuhiro ^a   Yanai, Kazuhiko ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Central nervous system; Gene knockout mice; Histamine H3 receptor; Morphine; Pain; Thioperamide

Indexed keywords

HISTAMINE H3 RECEPTOR; MORPHINE; THIOPERAMIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EXPERIMENTAL TEST; FORMALIN TEST; HOT PLATE TEST; LICKING; MOUSE; NERVE STIMULATION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PAW WITHDRAWAL TEST; PRIORITY JOURNAL; STIMULUS RESPONSE; TAIL FLICK TEST; THERMAL STIMULATION;

ANALGESICS, OPIOID; ANIMALS; HISTAMINE ANTAGONISTS; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PIPERIDINES; RECEPTORS, HISTAMINE H3; TIME FACTORS;

EID: 68749103154     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.036     Document Type: Article

References (49)

1. Arrang J.-M., Garbarg M., and Schwartz J.-C. Autoinhibition of histamine release mediated by a novel class (H3) of histamine receptor. Nature 302 (1983) 832-837
2. Arrang J.-M., Garbarg M., Lancelot J.-C., Lecomte J.-M., Pollard H., Robba M., Schunack W., and Schwartz J.-C. Highly potent and selective ligands for histamine H3-receptors. Nature 327 (1987) 117-123
3. Arrang J.M., Garbarg M., Lancelot J.C., Lecomte J.M., Pollard H., Robba M., Schunack W., and Schwartz J.C. Potential interest in powerful and specific ligands for the histamine H3 receptor. Allerg. Immunol. 20 (1988) 327-329
4. Blandina P., Giorgetti M., Bartolini L., Cecchi M., Timmerman H., Leurs R., Pepeu G., and Giovannini M.G. Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br. J. Pharmacol. 119 (1996) 1656-1664
5. Brabant C., Charlier Y., Quertemont E., and Tirelli E. The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice. Behav. Brain Res. 160 (2005) 161-168
6. Brown R.E., Stevens D.R., and Haas H.L. The physiology of brain histamine. Prog. Neurobiol. 63 (2001) 637-672
7. Calo G., Rizzi A., Marzola G., Guerrini R., Salvadori S., Beani L., Regoli D., and Bianchi C. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol. 125 (1998) 373-388
8. Cannon K.E., Nalwalk J.W., Stadel R., Ge P., Lawson D., Silos-Santiago I., and Hough L.B. Activation of spinal histamine H3 receptors inhibits mechanical nociception. Eur. J. Pharmacol. 470 (2003) 139-147
9. Cannon K.E., Chazot P.L., Hann V., Shenton F., Hough L.B., and Rice F.L. Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain 129 (2007) 76-92
10. Cannon K.E., and Hough L.B. Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors. J. Pain 6 (2005) 193-200
11. Coggeshall R.E., and Carlton S.M. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res. Brain Res. Rev. 24 (1997) 28-66
12. D Amour F.E., and Smith B.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72 (1941) 74-76
13. Farzin D., Asghari L., and Nowrouzi M. Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists. Pharmacol. Biochem. Behav. 72 (2002) 751-760
14. Fox G.B., Esbenshade T.A., Pan J.B., Radek R.J., Krueger K.M., Yao B.B., Browman K.E., Buckley M.J., Ballard M.E., Komater V.A., Miner H., Zhang M., Faghih R., Rueter L.E., Bitner R.S., Drescher K.U., Wetter J., Marsh K., Lemaire M., Porsolt R.D., Bennani Y.L., Sullivan J.P., Cowart M.D., Decker M.W., and Hancock A.A. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J. Pharmacol. Exp. Ther. 313 (2005) 176-190
15. Gbahou F., Vincent L., Humbert-Claude M., Tardivel-Lacombe J., Chabret C., and Arrang J.M. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives. Br. J. Pharmacol. 147 (2006) 744-754
16. Hancock A.A., Esbenshade T.A., Krueger K.M., and Yao B.B. Genetic and pharmacological aspects of histamine H3 receptor heterogeneity. Life Sci. 73 (2003) 3043-3072
17. Heron A., Rouleau A., Cochois V., Pillot C., Schwartz J.C., and Arrang J.M. Expression analysis of the histamine H(3) receptor in developing rat tissues. Mech. Dev. 105 (2001) 167-173
18. Hough L.B. Genomics meets histamine receptors: new subtypes, new receptors. Mol. Pharmacol. 59 (2001) 415-419
19. Huang L., Adachi N., Nagaro T., Liu K., and Arai T. Histaminergic involvement in neuropathic pain produced by partial ligation of the sciatic nerve in rats. Reg. Anesth. Pain Med. 32 (2007) 124-129
20. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
21. Jia F., Mobarakeh J.I., Dai H., Kato M., Xu A., Okuda T., Sakurai E., Okamura N., Takahashi K., and Yanai K. Blocking histamine H(1) improves learning and mnemonic dysfunction in mice with social isolation plus repeated methamphetamine injection. J. Pharmacol. Sci. 107 (2008) 167-174
22. Lamberti C., Bartolini A., Ghelardini C., and Malmberg-Aiello P. Investigation into the role of histamine receptors in rodent antinociception. Pharmacol. Biochem. Behav. 53 (1996) 567-574
23. Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., and Bartolini A. Role of histamine in rodent antinociception. Br. J. Pharmacol. 111 (1994) 1269-1279
24. Martinez-Mir M.I., Pollard H., Moreau J., Arrang J.M., Ruat M., Traiffort E., Schwartz J.C., and Palacios J.M. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res. 526 (1990) 322-327
25. Medhurst S.J., Collins S.D., Billinton A., Bingham S., Dalziel R.G., Brass A., Roberts J.C., Medhurst A.D., and Chessell I.P. Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain. Pain 138 (2008) 61-69
26. Mobarakeh J.I., Sakurada S., Katsuyama S., Kutsuwa M., Kuramasu A., Lin Z.Y., Watanabe T., Hashimoto Y., and Yanai K. Role of histamine H1 receptor in pain perception: a study of the receptor gene knockout mice. Eur. J. Pharmacol. 391 (2000) 81-89
27. Mobarakeh J.I., Sakurada S., Hayashi T., Orito T., Okuyama K., Sakurada T., Kuramasu A., Watanabe T., Watanabe T., and Yanai K. Enhanced antinociception by intrathecally-administered morphine in histamine H1 receptor gene knockout mice. Neuropharmacology 42 (2002) 1079-1088
28. Mobarakeh J.I., Takahashi K., Sakurada S., Nishino S., Watanabe H., Kato M., Naghdi N., and Yanai K. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 118 (2005) 254-262
29. Mobarakeh J.I., Takahashi K., Sakurada S., Kuramasu A., and Yanai K. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice. Neuropharmacology 51 (2006) 612-622
30. Morimoto T., Yamamoto Y., and Yamatodani A. Brain histamine and feeding behavior. Behav. Brain Res. 124 (2001) 145-150 (review)
31. Obara I., Parkitna J.R., Korostynski M., Makuch W., Kaminska D., Przewlocka B., and Przewlocki R. Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141 (2009) 283-291
32. Oluyomi A.O., and Hart S.L. Involvement of histamine in naloxone-resistant and naloxone-sensitive models of swim stress induced antinociception in the mouse. Neuropharmacology 30 (1991) 1021-1027
33. Ookuma K., Yoshimatsu H., Sakata T., Fujimoto K., and Fukagawa F. Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. 490 (1989) 268-275
34. Owen S.M., Sturman G., and Freeman P. Modulation of morphine-induced antinociception in mice by histamine H3-receptor ligands. Agents. Actions 41 Spec No (1994) C62-C63
35. Panula P., Flügge G., Fuchs E., Pirvola U., Auvinen S., and Airaksinen M.S. Histamine-immunoreactive nerve fibers in the mammalian spinal cord. Brain Res. 484 1-2 (1989) 234-239
36. Passani M.B., Bacciottini L., Mannaioni P.F., and Blandina P. Central histaminergic system and cognition. Neurosci. Biobehav. Rev. 24 (2000) 107-113 (review)
37. Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J.C., and Arrang J.M. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114 (2002) 173-193
38. Pollard H., Moreau J., Arrang S., and Airaksinen M.S. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience 52 (1993) 169-189
39. Rosland J.H., Tjolsen A., Maehle B., and Hole K. The formalin test in mice: effect of formalin concentration. Pain 42 (1990) 235-242
40. Rouleau A., Garbarg M., Ligneau X., Mantion C., Lavie P., Advenier C., Lecomte J.M., Krause M., Stark H., Schunack W., and Schwartz J.C. Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug. J. Pharmacol. Exp. Ther. 281 (1997) 1085-1094
41. Rouleau A., Stark H., Schunack W., and Schwartz J.C. Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug. J. Pharmacol. Exp. Ther. 295 (2000) 219-225
42. Sakurada S., Orito T., Sakurada C., Sato T., Hayashi T., Mobarakeh J.I., Yanai K., Onodera K., Watanabe T., and Sakurada T. Possible involvement of tachykinin NK(1) and NMDA receptors in histamine-induced hyperalgesia in mice. Eur. J. Pharmacol. 434 (2002) 29-34
43. Sakurada S., Watanabe H., Mizoguchi H., Yonezawa A., Orito T., Katsuyama S., Kuramasu A., Sakurada C., Yanai K., and Sakurada T. Involvement of the histaminergic system in the nociceptin-induced pain-related behaviors in the mouse spinal cord. Pain 112 (2004) 171-182
44. Schlicker E., Malinowska B., Kathmann M., and Gothert M. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam. Clin. Pharmacol. 8 (1994) 128-137
45. Wang H., and Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J. Comp. Neurol. 429 (2001) 590-600
46. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., and Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 295 (1984) 13-25
47. Yanai K., and Tashiro M. The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol. Ther. 113 (2007) 1-15
48. Yoshida A., Mobarakeh J.I., Sakurai E., Sakurada S., Orito T., Kuramasu A., Kato M., and Yanai K. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice. Eur. J. Pharmacol. 522 (2005) 55-62
49. Zimmermann P. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110